| Name | Title | Contact Details |
|---|
JAXJOX is a global fitness company revolutionizing the health and wellness industry through technology-enabled, connected at-home exercise equipment.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
AOS Research Services is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.
VASAMED, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Eden Prairie, MN. To find more information about VASAMED, Inc., please visit www.vasamed.com